Literature DB >> 219730

Interaction of neuromuscular blocking effects of neomycin and polymyxin B.

C Lee, A J de Silva.   

Abstract

Neomycin and polymyxin B produce neuromuscular blocks with distinct features by different mechanisms of action. In eight anesthetized cats the authors studied their interaction by examining the neuromuscular block produced by an equipotent mixture. Values of onset, potency, dose-response relations, duration and reversibility of block, the train-of-four and tetanic responses during block, the frequency-block relationships, and the posttetanic twitch behavior were well approximated by averaging the corresponding values previously reported for each antibiotic. Edrophonium, 0.2 mg/kg, reversed the block by 8 to 35 per cent. 4-Aminopyridine, 0.6 mg/kg, completely reversed the block and caused a long-lasting overshoot of the twitch response. The authors conclude that neomycin and polymyxin B are additive in neuromuscular effects, not only in terms of potency and duration, but also in terms of the characteristics of the blocks produced.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219730     DOI: 10.1097/00000542-197903000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

1.  Failure of neuromuscular blockade reversal after rocuronium in a patient who received oral neomycin.

Authors:  D L Hasfurther; P L Bailey
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

Review 2.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

3.  Effect of neomycin on post-tetanic twitch tension of the mouse diaphragm preparation.

Authors:  M C Tsai
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

4.  Respiratory Muscle Paralysis Associated With Colistin, Polymyxin B, and Muscle Relaxants Drugs: A Case Report.

Authors:  Thein Myint; Martin E Evans; Donna R Burgess; Richard N Greenberg
Journal:  J Investig Med High Impact Case Rep       Date:  2016-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.